Abstract
Diabetic Retinopathy (DR) is one of the most common complications of diabetes mellitus that affects the blood vessels of the retina, leading to blindness. The current approach of treatment based on anti-inflammatory, anti-angiogenesis drugs and laser photocoagulation are effective but also shows adverse affect in retinal tissues and that can even worsen the visual abilities. Thus, a safe and effective mode of treatment is needed to control or delaying the DR. Based on the earlier evidence of the potentiality of natural products as anti-oxidants, anti-diabetic and antitumor, medicinal plants may constitute a good therapeutic approach in the prevention of DR. Curcumin, constituents of dietary spice turmeric, has been observed to have therapeutic potential in the inhibition or slow down progression of DR. In this review, we summarize the therapeutic potentiality of curcumin in the delaying the DR through antioxidant, anti-inflammatory, inhibition of Vascular Endothelial Growth and nuclear transcription factors. The strength of involvement of curcumin in the modulation of genes action creates a strong optimism towards novel therapeutic strategy of diabetic retinopathy and important mainstay in the management of diabetes and its complications DR.
Keywords: Medicinal plants, curcumin, VEGF and diabetic retinopathy
Introduction
Diabetes mellitus is a major public health concern worldwide, where treatment would cost around 34 billion Dollars per year [1-3]. The exact mechanism of the development and progression of Diabetes and consequently DR is not well known. But it is thought that genetic and metabolic alterations play a significant role in the development and progression of diabetes and its complications. Diabetic Retinopathy (DR) is a complication of diabetes mellitus that affects the blood vessels of the retina, leading to blindness [4,5]. The current mode of treatment of DR is based on the control of oxidative stress; neural and vascular risk factors and laser photocoagulation [6,7] are effective but also exhibits adverse side effects. Therefore, safe and sound mode of management is needed to control the development and progression of DR. Based on the evidence during last two decades of medicinal plants in various diseases, naturally occurring antioxidants, anti-tumour, anti-diabetic activities in medicinal plants may constitute a good therapeutic approach in the prevention of various diseases [8-10]. The use of medicinal plants and its products has been discussed in modern scientific literatures, Ayurveda, Unani medicine as well as in religious books.
The Holy Prophet Mohammed (Peace Be Upon Him) used various plants and recommended various medicinal plants for cure of numerous diseases [11,12]. The constituent of turmeric, Curcumin is derived from the rhizome of the Indian plant Curcuma longa and shows a vital role in disease control. Earlier studies reported that curcumin as anti-protozoal, anti-bacterial, anti-oxidant, anti-tumour and anti-diabetic [13-17] and play a significant role in the delaying or inhibition of various diseases. Turmeric and its constituents are good substitute in the prevention or slow down the development of diabetes and Diabetic Retinopathy and also they are inexpensive, safe and easy to access. In this review, we sum up the understanding of effect of curcumin in the prevention or slow down the Diabetic Retinopathy through the regulation of gene action and other factors.
Botanical information of turmeric plant
Family: Zingiberaceae; Genus: Curcuma; Most common species: Curcuma longa; Number of Curcuma Species: more than sixty; Part used: Rhizome (Root); Origin: South Asia; mainly China and India.
Composition, structure and function of turmeric and their constituents
Turmeric is a spice that is often used as food flavoring in Asian dishes (Figure 1). It belongs to the ginger family. Earlier investigators have shown that turmeric and their constituents play a vital role in the prevention of various types of diseases. Turmeric contains curcuminoids, which includes curcumin (Figure 2), demethoxycurcumin and bisdemethoxycurcumin. Curcumin play a vital effect in prevention of diseases and has been proved as anti-oxidant [18,19].
All constituents of turmeric including curcumin play an important effect in the prevention of various types of diseases including Diabetic Retinopathy [20-25]. Mainly two types of compound have been identified in turmeric as phenolic compounds and terpenoids. Terpenoids, a subclass of the prenyllipids synthesized by plants such as turmeric and are the most used group of natural products. The terpenoids, is component found in turmeric and has shown anti-bacterial role in earlier study [26].
The exact mechanism of action of terpenoids in the regulation of DR is not completely known but it might be has significant role in activation and inhibition of gene action. An experimental study in animal model showed that constituents of turmeric such as curcuminoids and sesquiterpenoids acts as hypoglycemic through the activation of peroxisome proliferators-activated receptor-γ (PPAR-γ) and also suppression of high blood glucose levels [27,28]. Curcumin is a phenolic compound of turmeric that plays a vital role in regulation of oxidative stress and gene action [29-32]. The constituents of turmeric play vital role in the prevention of DR through activation and inactivation of genetic pathways (Figure 3).
Effect of curcumin in the prevention or slowdown of diabetic retinopathy
Diabetic Retinopathy (DR) is a complication of diabetes mellitus that affects the blood vessels of the retina [4,5]. The exact causes of the development and progression of DR is not fully known. But it is thought that various factor such as oxidative stress, genetic and metabolic alterations involve in the development and progression of diabetes and its complication DR. The current approach based on allopath treatment as anti-inflammatory and anti-angiogenesis drugs are expensive and also show an adverse side effect in the retinal tissues. Natural products in the form of turmeric and its constituents curcumin play an important role in the prevention of DR.
Antioxidant activity of curcumin
Antioxidants are also known as free radical scavengers. In our body free radical production is balanced by the antioxidative defence system [33] and imbalance between reactive oxygen species (ROS) generation and its neutralizion by antioxidant defences [34,35] creates oxidative stress.
The high oxidative stress [36-39] and reactive oxygen species (ROS) shows an important link between high glucose and the metabolic abnormalities and finally involve in the development of diabetic complications [40]. High glucose concentrations play an important effect in free-radical production via advanced glycation end products (AGEs) [41], protein kinase C activation [42], and aldose reductase pathway [43].
The prevention of activities of free radical is important step in the management of disease. Medicinal plants and their constituents play a vital and significant action in neutralize or inhibit the free radical through antioxidant activity. The phytochemicals shows effect as antioxidants by scavenging free radicals, and many have therapeutic potential for free radical associated disorders [44,45]. Curcumin, chief constituents of turmeric play significant role in diseases prevention through the antioxidant activities. An experiment based on diabetes induced animal model showed that curcumin plays a significant effect to rescue the retinal glutathione levels, important determinant of redox signaling [46].
Earlier reports have also shown that Diabetic-induced oxidative stress shows a role in the activation of transcription factor, NF-κB in the retina [47-49]. Also turmeric and its constituents curcumin play a vital role in the prevention of diabetes-induced decrease in the total antioxidant capacity of the retina [50,51]. Moreover, curcumin inhibits the activation of NF-κB, accumulation of 8-OHdG and nitrotyrosine in the retina in diabetes [52]. A recent experimental study has shown that retinal glutathione levels and antioxidant enzymes such as superoxide dismutase and catalase were significantly decrease in the diabetic group; on the other hand, curcumin positively modulated the antioxidant system [52]. The curcumin with dose (1 g/kg body weight) significantly increases the endogenous glutathione levels and the activities of superoxide dismutase and catalase [52].
Anti-inflammatory effect of curcumin
Inflammation is one of the important physiologic defence mechanisms against various factors such as infection, burn, toxic chemicals, allergens and other stimuli [53]. The uncontrolled inflammation plays an important role in various types of chronic illnesses [54].
The current treatment based on anti-inflammaotry drugs are effective and give immediate response but these drugs have adverse side effect. However, safe and effective natural product is needed to control the inflammatory activity.
Earlier studies have shown that turmeric and their constituents play a significant effect in the control of various diseases via anti-inflammatory action. An important findings regarding turmeric effect have shown that inflammatory biomarkers such as 5-hydroxy-eicosatetraenoic acid (5-HETE), cyclooxygenase (COX), and lipoxygenase (LOX) are targeted by curcumin and curcumin’s anti-inflammatory activities also showed the inhibition of arachidonic acid metabolism [55,56].
Transcription factors nuclear factor-κB (NF-κB) shows a vital role in regulation of expression of genes [57,58]. Suppression of NF-κB activation shows a role in the down-regulation of COX-2 and iNOS expression, inhibiting the inflammatory process and tumorigenesis [59,60]. Curcumin have potential benefits in inhibiting the development of Diabetic Retinopathy [51]. Furthermore, curcumin also showed vital effect in both oxidative changes as well as tumor necrosis factor (TNF)-α inhibition in the retina of hyperglycemic rats [51,52]. Another study in the support of curcumin effect have shown that dietary supplementation of curcumin significantly inhibits cytokines, such as interleukin 1beta, tumor necrosis factor alpha, VEGF and the diabetes-induced activation of NF-kB in the retinas of STZ-induced diabetic rats [51,52].
Effect of curcumin on angiogenesis
Angiogenesis process is highly regulated process; angiogenic factors such as vascular endothelial growth factor (VEGF) which act as stimulators, angiostatin and pigment epithelium-derived factor (PEDF) which act as angiogenic inhibitors [61-64]. VEGF is important angiogeneic factor in the development and progression of various types of diseases and play a vital role in the development of Diabetic Retinopathy (Figure 4). The present treatment based on anti-angiogenic factor is effective but also shows side effect. Therefore, a safe and effective drug is required to control the DR. Curcumin, is a safe and inexpensive substitute in the management of Diabetic Retinopathy via anti-angiogenic effect. A study reported that curcumin inhibits the increased VEGF levels in the retina and abolish IL-18 induced increase in VEGF production [51]. Another study in animal model showed that VEGF expression was high in diabetic retina when compared to control retina at both transcript and protein level whereas curcumin treated group showed a significant inhibition of the expression of VEGF in diabetic retina [65].
Earlier report in vitro showed that curcumin shows a vital effect in the induction of apoptosis in human retinal endothelial cells and decrease VEGF release [51]. Curcumin has shown effect in the inhibition of PKC βII translocation induced by VEGF in HRECs and PKC activation also up regulate VEGF expression [66].
Important recent study based on clinical trial has shown that anti-VEGF agents are efficient in the treatment of DR [67,68].
Stromal cell-derived factor 1 (SDF-1) is an important factor in angiogenesis and high level of SDF-1 has been noticed in diabetic subjects with proliferative Diabetic Retinopathy (PDR) [69,70]. Curcumin showed a significant effect in decrease the stromal cell-derived factor-1 induced migration of human retinal endothelial cells (HRECs) [71].
Effect of curcumin on the transcription factor EGR-1
EGR-1 is transcription factor and encodes a nuclear phosphoprotein involved in the various processes in response to signals [72-75]. EGR-1 role has been observed in tumour, diabetes and other disease. The regulation or suppression of EGR1 is critical step in the control of diseases. An important study showed that curcumin inhibit the EGR1 and EGR1 mediated gene expression in endothelial cells and fibroblast cells [76]. Another finding in support of curcumin effect has shown that Curcumin down-regulated the expression EGR1 and Icam1 in 661W cells and EGR1 in rat retina with light-damage [77].
Some others genes alteration such as PPAR-γ and histone acetylation has been noticed in the development of diabetes and DR.
A report in the support of curcumin effect has shown that oral administration of curcumin with dose 0.05% w/w in diets for 9 weeks inhibited the diabetes-induced increase in acetylated histones in the retinas [78]. Curcumin suppress blood glucose levels, increase the antioxidant status of pancreatic β-cells, and enhance the activation of PPAR-γ [27].
The study based on clinical trials showed that the effect of curcumin in the control of various types of diseases including DR [79-83]. Numerous clinical trial based study has been completed and several study are in the process to evaluate the effect of curcumin in the management of cancer, diabetes and other diseases. A study based on curcumin has shown Curcumin showed a vital role in the general health improvement of colorectal cancer via the mechanism of increased p53 expression in tumor cells [79].
Several reports has shown the effect of curcumin in treatment of eye related diseases or evaluated the efficacy of curcumin in treatment of eye diseases [84-86]. Based on clinical trial study on the effectiveness of curcumin, curcumin is safe remedy in the treatment of eye related diseases.
Conclusions
Safe, effective and inexpensive treatment is needed to control development and progression of DR. The genetic alterations are a major culprit in the development of diabetes and its complication DR. The turmeric and its constituents act as molecular targets and it has proved therapeutic potential in DR prevention. The strength of involvement of curcumin in the control of genes action creates a strong optimism towards the novel therapeutic strategy of diabetic retinopathy. The features of being no side effect, affordable and easy to access, turmeric and its constituents curcumin, is the mainstay in the control of Diabetic Retinopathy.
Disclosure of conflict of interest
The authors have no conflict of interests to disclose.
References
- 1.Lusignan S, Sismanidis C, Carey IM, DeWilde S, Richards N, Cook DG. Trends in the prevalence and management of diagnosed type 2 diabetes 1994-2001 in England and Wales. BMC Fam Pract. 2005;6:13. doi: 10.1186/1471-2296-6-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431. doi: 10.2337/diacare.21.9.1414. [DOI] [PubMed] [Google Scholar]
- 3.Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–1053. doi: 10.2337/diacare.27.5.1047. [DOI] [PubMed] [Google Scholar]
- 4.Abu El-Asrar AM. Role of Inflammation in the Pathogenesis of Diabetic Retinopathy. Middle East Afr J Ophthalmol. 2012;19:70–74. doi: 10.4103/0974-9233.92118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Aldebasi YH, Rahmani AH, Khan AA, Aly SM. The effect of vascular endothelial growth factor in the progression of bladder cancer and Diabetic Retinopathy. Int J Clin Exp Med. 2013;6:239–251. [PMC free article] [PubMed] [Google Scholar]
- 6.Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004;25:612–628. doi: 10.1210/er.2003-0019. [DOI] [PubMed] [Google Scholar]
- 7.Tesfaye S, Chaturvedi N, Eaton SEM, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352:341–350. doi: 10.1056/NEJMoa032782. [DOI] [PubMed] [Google Scholar]
- 8.Farah N, Benghuzzi H, Tucci M, Cason Z. The effects of isolated antioxidants from black seed on the cellular metabolism of A549 cells. Biomed Sci Instrum. 2005;41:211–6. [PubMed] [Google Scholar]
- 9.Biglari F, AlKarkhi AFM, Easa AM. Antioxidant activity and phenolic content of various date palm (Phoenix dactylifera) fruits from Iran. Food Chemistry. 2008;107:1636–1641. [Google Scholar]
- 10.Ashraf SS, Rao MV, Kaneez FS, Qadri S, Al-Marzouqi AH, Chandranath IS, Adem A. Nigella sativa Extract as a Potent Antioxidant for Petrochemical-Induced Oxidative Stress. J Chromatogr Sci. 2011;49:321–326. doi: 10.1093/chrsci/49.4.321. [DOI] [PubMed] [Google Scholar]
- 11.Dar-ul-Iman Healing, 2000. Food of the Prophet (Sallallaho Alayhi Wasallam) Available at: http://chishti.org/foods_of_the_prophet. Accessed March 13, 2009.
- 12.Marwat SK, Khan MA, Rehman F, Bhatti IU. Aromatic Plant Species Mentioned in the Holy Qura’n and Ahadith and Their Ethnomedicinal Importance. Pak J Nutr. 2009;8:1472–1479. [Google Scholar]
- 13.Motterlini R, Foresti R, Bassi R, Green CJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med. 2000;28:1303–1312. doi: 10.1016/s0891-5849(00)00294-x. [DOI] [PubMed] [Google Scholar]
- 14.Jayaprakasha GK, Rao LJ, Sakariah KK. Antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Chemistry. 2006;98:720–724. doi: 10.1021/jf025506a. [DOI] [PubMed] [Google Scholar]
- 15.Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003;23:363–398. [PubMed] [Google Scholar]
- 16.Nakamura K, Yasunaga Y, Segawa T, Ko D, Moul JW, Srivastava S, Rhim JS. Curcumin downregulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol. 2002;21:825–30. [PubMed] [Google Scholar]
- 17.Han SS, Seo HJ, Surh YJ. Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol. 2002;35:337–342. doi: 10.5483/bmbrep.2002.35.3.337. [DOI] [PubMed] [Google Scholar]
- 18.Ahsan H, Parveen N, Khan NU, Hadi SM. Prooxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem Biol Interact. 1999;121:161–175. doi: 10.1016/s0009-2797(99)00096-4. [DOI] [PubMed] [Google Scholar]
- 19.Osawa T, Sugiyama Y, Inayoshi M, Kawakishi S. Antioxidative activity of tetrahydrocurcuminoids. Biosci Biotechnol Biochem. 1995;59:1609–1612. doi: 10.1271/bbb.59.1609. [DOI] [PubMed] [Google Scholar]
- 20.Babu PS, Srinivasan K. Influence of dietary curcumin and cholesterol on theprogression of experimentally induced diabetes in albino rat. Mol Cell Biochem. 1995;152:13–21. doi: 10.1007/BF01076459. [DOI] [PubMed] [Google Scholar]
- 21.Babu PS, Srinivasan K. Hypolipidemic action of curcumin, the active principle ofturmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem. 1997;166:169–75. doi: 10.1023/a:1006819605211. [DOI] [PubMed] [Google Scholar]
- 22.Babu PS, Srinivasan K. Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Mol Cell Biochem. 1998;181:87–96. doi: 10.1023/a:1006821828706. [DOI] [PubMed] [Google Scholar]
- 23.Singh N, Shrivastav A, Sharma RK. Curcumin induces caspase and calpain-dependent apoptosis in HT29 human colon cancer cells. Mol Med Rep. 2009;2:627–631. doi: 10.3892/mmr_00000148. [DOI] [PubMed] [Google Scholar]
- 24.Patel BB, Gupta D, Elliott AA, Sengupta V, Yu Y, Majumdar AP. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R. Anticancer Res. 2010;30:319–25. [PMC free article] [PubMed] [Google Scholar]
- 25.Cai XZ, Wang J, Li XD, Wang GL, Liu FN, Cheng MS, Li F. Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther. 2009;8:1360–1368. doi: 10.4161/cbt.8.14.8720. [DOI] [PubMed] [Google Scholar]
- 26.Negi PS, Jayaprakasha GK, Jagan Mohan Rao L, Sakariah KK. Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture. J Agric Food Chem. 1999;47:4297–4300. doi: 10.1021/jf990308d. [DOI] [PubMed] [Google Scholar]
- 27.Nishiyama T, Mae T, Kishida H, Tsukagawa M, Mimaki Y, Kuroda M, Sashida Y, Takahashi K, Kawada T, Nakagawa K, Kitahara M. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L. ) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J Agric Food Chem. 2005;53:959–963. doi: 10.1021/jf0483873. [DOI] [PubMed] [Google Scholar]
- 28.Koo HJ, Gang DR. Suites of Terpene Synthases Explain Differential Terpenoid Production in Ginger and Turmeric Tissues. PLoS One. 2012;7:e51481. doi: 10.1371/journal.pone.0051481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Reddy AC, Lokesh BR. Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrousiron. Mol Cell Biochem. 1994;137:1–8. doi: 10.1007/BF00926033. [DOI] [PubMed] [Google Scholar]
- 30.Binion DG, Otterson MF, Rafiee P. Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut. 2008;57:1509–15017. doi: 10.1136/gut.2008.152496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Chakraborty G, Jain S, Kale S, Raja R, Kumar S, Mishra R, Kundu GC. Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression. Mol Med Rep. 2008;1:641–646. doi: 10.3892/mmr_00000005. [DOI] [PubMed] [Google Scholar]
- 32.Huang Q, Sheibani N. High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs. Am J Physiol Cell Physiol. 2008;295:C1647–1657. doi: 10.1152/ajpcell.00322.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Shyur LF, Tsung JH, Chen JH, Chiu CY, Lo CP. Antioxidant Properties of Extracts from MedicinalPlants Popularly Used in Taiwan Oxidatative stress play a siginificant effect in the pathogenesis of various types of disease. Int J Appl Sci Eng. 2005;3:195–202. [Google Scholar]
- 34.Ceriello A, Mercuri F, Quagliaro L, Assaloni R, Motz E, Tonutti L, Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia. 2001;44:834–838. doi: 10.1007/s001250100529. [DOI] [PubMed] [Google Scholar]
- 35.Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–1625. doi: 10.2337/diabetes.54.6.1615. [DOI] [PubMed] [Google Scholar]
- 36.Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Rad Biol Med. 1997;22:587–592. doi: 10.1016/s0891-5849(96)00347-4. [DOI] [PubMed] [Google Scholar]
- 37.Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Rad Bio Med. 2003;35:1491–1499. doi: 10.1016/j.freeradbiomed.2003.08.018. [DOI] [PubMed] [Google Scholar]
- 38.Kowluru RA, Atasi L, Ho YS. Role of mitochondrial superoxide dismutase in the development of Diabetic Retinopathy. Invest Ophthal Vis Sci. 2006;47:1594–1599. doi: 10.1167/iovs.05-1276. [DOI] [PubMed] [Google Scholar]
- 39.Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820. doi: 10.1038/414813a. [DOI] [PubMed] [Google Scholar]
- 40.Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of a tioxidants on the development of retinopathy. Diabetes. 2001;50:1938–1942. doi: 10.2337/diabetes.50.8.1938. [DOI] [PubMed] [Google Scholar]
- 41.Bierhaus A, Hofmann MA, Ziegler R, Nawroth P. AGE and other interaction with AGE-receptors in vascular disease and diabetes-I. The AGE concept. Cardiovasc Res. 1998;37:586–590. doi: 10.1016/s0008-6363(97)00233-2. [DOI] [PubMed] [Google Scholar]
- 42.King GL, Ishii H, Koya D. Diabetic vascular dysfunction: Amodel of excessive activation of protein kinase C. Kidney Int. 1997;52:S77–S85. [PubMed] [Google Scholar]
- 43.Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Van Den Enden M, Kilo C, Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993;42:801–813. doi: 10.2337/diab.42.6.801. [DOI] [PubMed] [Google Scholar]
- 44.Lee YM, Kim H, Hong EK, Kang BH, Kim SJ. Water extract of 1:1 mixture of Phellodendron cortex and Aralia cortex has inhibitory effects on oxidative stress in kidney of diabetic rats. J Ethnopharmacol. 2000;73:429–436. doi: 10.1016/s0378-8741(00)00302-0. [DOI] [PubMed] [Google Scholar]
- 45.Hausladen A, Stamler JS. Nitrosative stress. Methods Enzymol. 1999;300:389–395. doi: 10.1016/s0076-6879(99)00143-3. [DOI] [PubMed] [Google Scholar]
- 46.King GL. Hyperglycemia and the pathogenesis of Diabetic Retinopathy. J Gen Intern Med. 1986;1:133–134. doi: 10.1007/BF02599819. [DOI] [PubMed] [Google Scholar]
- 47.Kowluru RA, Kern TS, Engerman RL, Armstrong D. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes. 1996;45:1233–1237. doi: 10.2337/diab.45.9.1233. [DOI] [PubMed] [Google Scholar]
- 48.Obrosova IG, Julius UA. Role for poly(ADP-ribose) polymerase activation in diabetic nephropathy, neuropathy and retinopathy. Curr Vasc Pharmacol. 2005;3:267–283. doi: 10.2174/1570161054368634. [DOI] [PubMed] [Google Scholar]
- 49.Kowluru RA. Diabetic Retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal. 2005;7:1581–1587. doi: 10.1089/ars.2005.7.1581. [DOI] [PubMed] [Google Scholar]
- 50.Kowluru RA, Kowluru V, Xiong Y, Ho YS. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Rad Biol Med. 2006;41:1191–1196. doi: 10.1016/j.freeradbiomed.2006.01.012. [DOI] [PubMed] [Google Scholar]
- 51.Kowluru RA, Kanwar M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond) 2007;4:8. doi: 10.1186/1743-7075-4-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Gupta SK, Kumar B, Nag TC, Agrawal SS, Agrawal R, Agrawal P, Saxena R, Srivastava S. Curcumin prevents experimental Diabetic Retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. J Ocul Pharmacol Ther. 2011;27:123–30. doi: 10.1089/jop.2010.0123. [DOI] [PubMed] [Google Scholar]
- 53.Sharma GN, Dubey SK, Sati N, Sanadya J. Anti-inflammatory Activity and Total Flavonoid Content of Aegle marmelos Seeds. Int J Pharm Sci Drug Res. 2011;3:214–8. [Google Scholar]
- 54.Kumar V, Abbas AK, Fausto N. Robbins and Cotran: Pathologic basis of disease. 7th edition. Philadelphia, Pennsylvania: Elsevier Saunders; 2004. pp. 47–86. [Google Scholar]
- 55.Flynn DL, Rafferty MF, Boctor AM. Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med. 1986;22:357–360. doi: 10.1016/0262-1746(86)90146-0. [DOI] [PubMed] [Google Scholar]
- 56.Huang MT, Lysz T, Ferraro T, Abidi TF, Laskin JD, Conney AH. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 1991;51:813–819. [PubMed] [Google Scholar]
- 57.Chen F, Castranova V, Shi X, Demers KM. New insights into the role of nuclear factor-kB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem. 1999;45:7–17. [PubMed] [Google Scholar]
- 58.Gius D, Botero A, Shah S, Curry HA. Oxidation/reduction status in the regulation of transcription factors NF-kB and AP-1. Toxicol Lett. 1999;106:93–106. doi: 10.1016/s0378-4274(99)00024-7. [DOI] [PubMed] [Google Scholar]
- 59.Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NFkappa B activation. Mutat Res. 2001;480-481:243–268. doi: 10.1016/s0027-5107(01)00183-x. [DOI] [PubMed] [Google Scholar]
- 60.Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999;163:3474–3483. [PubMed] [Google Scholar]
- 61.Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci. 1997;22:251–256. doi: 10.1016/s0968-0004(97)01074-8. [DOI] [PubMed] [Google Scholar]
- 62.Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285:245–248. doi: 10.1126/science.285.5425.245. [DOI] [PubMed] [Google Scholar]
- 63.Jimenez B, Volpert OV. Mechanistic insights on the inhibition of tumor angiogenesis. J Mol Med. 2001;78:663–672. doi: 10.1007/s001090000178. [DOI] [PubMed] [Google Scholar]
- 64.Rena JG, Jie C, Talbot C. How PEDF prevents angiogenesis: a hypothesized pathway. Med Hypotheses. 2005;64:74–8. doi: 10.1016/j.mehy.2004.05.016. [DOI] [PubMed] [Google Scholar]
- 65.Mrudula T, Suryanarayana P, Srinivas PN, Reddy GB. Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. Biochem Biophys Res Commun. 2007 Sep 21;361:528–32. doi: 10.1016/j.bbrc.2007.07.059. [DOI] [PubMed] [Google Scholar]
- 66.Williams B, Gallacher B, Patel H, Orme C. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes. 1997;46:1497–1503. doi: 10.2337/diab.46.9.1497. [DOI] [PubMed] [Google Scholar]
- 67.Jeganathan VS. Anti-angiogenesis drugs in Diabetic Retinopathy. Curr Pharm Biotechnol. 2011;12:369–372. doi: 10.2174/138920111794480525. [DOI] [PubMed] [Google Scholar]
- 68.Willard AL, Herman IM. Vascular complications and diabetes: current therapies and future challenges. J Ophthalmol. 2012;2:1–14. doi: 10.1155/2012/209538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Salvucci O, Basik M, Yao L, Bianchi R, Tosato G. Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma. J Leukoc Biol. 2004;76:217–226. doi: 10.1189/jlb.1203609. [DOI] [PubMed] [Google Scholar]
- 70.Butler JM, Guthrie SM, Koc M, Afzal A, Caballero S, Brooks HL, Mames RN, Segal MS, Grant MB, Scott EW. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest. 2005;115:86–93. doi: 10.1172/JCI22869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Sameermahmood Z, Balasubramanyam M, Saravanan T, Rema M. Curcumin modulates SDF-1alpha/CXCR4- induced migration of human retinal endothelial cells (HRECs) Invest Ophthalmol Vis Sci. 2008;49:3305–3311. doi: 10.1167/iovs.07-0456. [DOI] [PubMed] [Google Scholar]
- 72.Sukhatme VP, Cao X, Chang LC, Tsai-Morris CH, Stamenkovitch D, Ferreira PCP, Cohen DR, Edwards SA, Shows TB, Curran T, Le Beau MM, Adamson ED. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation and after cellular depolarization. Cell. 1988;53:37–43. doi: 10.1016/0092-8674(88)90485-0. [DOI] [PubMed] [Google Scholar]
- 73.Milbrandt J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science. 1987;238:797–799. doi: 10.1126/science.3672127. [DOI] [PubMed] [Google Scholar]
- 74.Liu C, Rangnekar VM, Adamson E, Mercola D. Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther. 1998;5:3–28. [PubMed] [Google Scholar]
- 75.Huang RP, Wu JX, Fan Y, Adamson ED. UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol. 1996;133:211–220. doi: 10.1083/jcb.133.1.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Pendurthi UR, Mohan Rao LV. Suppression of Transcription Factor Egr-1 by Curcumin. Thromb Res. 2000;97:179–189. doi: 10.1016/s0049-3848(99)00148-6. [DOI] [PubMed] [Google Scholar]
- 77.Mandal MNA, Patlolla JMR, Zheng L, Agbaga M, Tran JA, Wicker L, Kasus-Jacobi A, Elliott MH, Rao CV, Anderson RE. Curcumin Protects Retinal Cells from Light- and Oxidant Stress-induced Cell Death. Free Radic Biol Med. 2009;46:672–679. doi: 10.1016/j.freeradbiomed.2008.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Wang L, Sun Y, Huang K, Zheng L. Curcumin, a potential therapeutic candidate for retinal diseases. Mol Nutr Food Res. 2013;57:1557–1568. doi: 10.1002/mnfr.201200718. [DOI] [PubMed] [Google Scholar]
- 79.He ZY, Shi CB, Wen H, Li FL, Wang BL, Wang J. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest. 2011;29:208–213. doi: 10.3109/07357907.2010.550592. [DOI] [PubMed] [Google Scholar]
- 80.Durgaprasad S, Pai CG, Vasanthkumar , Alvres JF, Namitha S. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res. 2005;122:315–3. [PubMed] [Google Scholar]
- 81.Khajehdehi P, Pakfetrat M, Javidnia K, Azad F, Malekmakan L, Nasab MH, Dehghanzadeh G. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-beta and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scand J Urol Nephrol. 2011;45:365–370. doi: 10.3109/00365599.2011.585622. [DOI] [PubMed] [Google Scholar]
- 82.Usharani P, Mateen AA, Naidu MU, Raju YS, Chandra N. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D. 2008;9:243–250. doi: 10.2165/00126839-200809040-00004. [DOI] [PubMed] [Google Scholar]
- 83.Gupta SC, Patchva S, Aggarwal BB. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials. AAPS J. 2013;15:195–218. doi: 10.1208/s12248-012-9432-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Lal B, Kapoor AK, Asthana OP, Agrawal PK, Prasad R, Kumar P, Srimal RC. Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res. 1999;13:318–322. doi: 10.1002/(SICI)1099-1573(199906)13:4<318::AID-PTR445>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
- 85.Allegri P, Mastromarino A, Neri P. Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up. Clin Ophthalmol. 2010;4:1201–1206. doi: 10.2147/OPTH.S13271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Mazzolani F. Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy. Clin Ophthalmol. 2012;6:801–806. doi: 10.2147/OPTH.S31859. [DOI] [PMC free article] [PubMed] [Google Scholar]